ICU Medical, Inc.
General ticker "ICUI" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $3.4B (TTM average)
ICU Medical, Inc. follows the US Stock Market performance with the rate: 27.4%.
Estimated limits based on current volatility of 2.1%: low 138.40$, high 144.36$
Factors to consider:
- Total employees count: 15000 (+7.1%) as of 2024
- US accounted for 64.3% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Market competition, Economic downturns and volatility, Cybersecurity threats, Integration failure, Management distraction
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [102.90$, 158.86$]
- 2026-12-31 to 2027-12-31 estimated range: [98.04$, 153.57$]
Financial Metrics affecting the ICUI estimates:
- Negative: with PPE of 18.9 at the end of fiscal year the price was very high
- Positive: -4.75 < Operating profit margin, % of 4.80
- Positive: Investing cash flow per share per price, % of 3.39 > -0.63
- Positive: 42.68 < Shareholder equity ratio, % of 52.43 <= 64.29
- Positive: -3.43 < Return on assets ratio (scaled to [-100,100]) of 0.02
- Negative: Industry operating cash flow per share per price (median), % of 1.99 <= 5.46
- Positive: Interest expense per share per price, % of 2.92 <= 3.28
- Positive: 0.01 < Operating cash flow per share per price, % of 4.99
Short-term ICUI quotes
Long-term ICUI plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2,259.13MM | $2,382.05MM | $2,230.03MM |
| Operating Expenses | $2,236.30MM | $2,339.08MM | $2,123.07MM |
| Operating Income | $22.82MM | $42.96MM | $106.95MM |
| Non-Operating Income | $-101.12MM | $-108.98MM | $-103.78MM |
| Interest Expense | $95.22MM | $95.75MM | $105.38MM |
| R&D Expense | $85.34MM | $88.61MM | $87.50MM |
| Income(Loss) | $-78.30MM | $-66.01MM | $3.17MM |
| Taxes | $-48.64MM | $51.68MM | $2.44MM |
| Profit(Loss)* | $-29.66MM | $-117.69MM | $0.73MM |
| Stockholders Equity | $2,123.41MM | $1,965.23MM | $2,123.82MM |
| Inventory | $709.36MM | $584.68MM | $615.86MM |
| Assets | $4,378.44MM | $4,203.93MM | $4,050.51MM |
| Operating Cash Flow | $166.20MM | $204.03MM | $179.85MM |
| Capital expenditure | $93.67MM | $79.37MM | $88.04MM |
| Investing Cash Flow | $-87.95MM | $-88.96MM | $122.23MM |
| Financing Cash Flow | $-35.98MM | $-55.80MM | $-311.52MM |
| Earnings Per Share** | $-1.23 | $-4.83 | $0.03 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.